Tred Avon Family Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Buy
10,535
+642
+6% +$142K 0.76% 26
2025
Q4
$2.26M Buy
9,893
+1,289
+15% +$294K 0.74% 28
2025
Q3
$1.99M Buy
+8,604
New +$1.75M 0.68% 30

Other funds holding ABBV

Tred Avon Family Wealth's ABBV Position: Q1 2026 in Review

Tred Avon Family Wealth increased its AbbVie (ABBV) stake by 6.5% in Q1 2026, buying an estimated $142K and bringing the position to 10,535 shares worth $2.29M. The position accounts for 0.76% of the portfolio, ranked #26.

Tred Avon Family Wealth first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Tred Avon Family Wealth held 10,535 shares of AbbVie worth $2.29M as of Q1 2026.
  • Tred Avon Family Wealth bought 642 AbbVie shares in Q1 2026, an estimated $142K.
  • AbbVie made up 0.76% of Tred Avon Family Wealth's portfolio in Q1 2026, its #26 holding.
  • Tred Avon Family Wealth first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tred Avon Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.